Captrust Financial Advisors bought a new stake in shares of Express Scripts Holding (NASDAQ:ESRX) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 18,698 shares of the company’s stock, valued at approximately $1,396,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in ESRX. Bank of New York Mellon Corp lifted its holdings in Express Scripts by 8.7% during the fourth quarter. Bank of New York Mellon Corp now owns 8,287,905 shares of the company’s stock valued at $618,609,000 after purchasing an additional 666,754 shares in the last quarter. Nordea Investment Management AB lifted its holdings in Express Scripts by 2.6% during the third quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock valued at $462,551,000 after purchasing an additional 188,528 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Express Scripts by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 6,608,383 shares of the company’s stock valued at $492,297,000 after purchasing an additional 32,548 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Express Scripts by 1.3% during the third quarter. Dimensional Fund Advisors LP now owns 6,545,076 shares of the company’s stock valued at $414,419,000 after purchasing an additional 86,800 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its holdings in Express Scripts by 23.5% during the third quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock valued at $331,374,000 after purchasing an additional 996,816 shares in the last quarter. Institutional investors own 89.08% of the company’s stock.
Several brokerages have weighed in on ESRX. Mizuho set a $86.00 price target on shares of Express Scripts and gave the company a “hold” rating in a report on Wednesday, January 24th. Maxim Group downgraded shares of Express Scripts from a “buy” rating to a “hold” rating in a report on Thursday, March 8th. Jefferies Group downgraded shares of Express Scripts from a “buy” rating to a “hold” rating and set a $91.00 price target on the stock. in a report on Thursday, March 8th. Sanford C. Bernstein raised shares of Express Scripts from an “underperform” rating to a “market perform” rating in a report on Monday. Finally, SunTrust Banks reaffirmed a “buy” rating and set a $95.00 price target on shares of Express Scripts in a report on Friday, January 12th. Three research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and seven have assigned a buy rating to the stock. Express Scripts currently has a consensus rating of “Hold” and a consensus target price of $81.97.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, February 27th. The company reported $2.16 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.09 by $0.07. The company had revenue of $25.38 billion for the quarter, compared to the consensus estimate of $25.07 billion. Express Scripts had a net margin of 4.51% and a return on equity of 25.19%. Express Scripts’s revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.88 earnings per share. research analysts expect that Express Scripts Holding will post 9.35 EPS for the current fiscal year.
Express Scripts announced that its board has initiated a share buyback plan on Monday, December 18th that allows the company to buyback 45,000,000 outstanding shares. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback plans are typically an indication that the company’s leadership believes its shares are undervalued.
In related news, VP Everett Neville sold 4,895 shares of the company’s stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $75.26, for a total transaction of $368,397.70. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Glen D. Stettin sold 3,448 shares of the company’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 21,896 shares of company stock worth $1,617,903. 0.68% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Captrust Financial Advisors Buys New Stake in Express Scripts Holding (ESRX)” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/03/14/captrust-financial-advisors-buys-new-stake-in-express-scripts-holding-esrx.html.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.